Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators

Francesca Pennati, Caterina Salito, Irene Borzani, Giulia Cervellin, Simone Gambazza, Riccardo Guarise, Maria Chiara Russo, Carla Colombo, Andrea Aliverti

Source: Eur Respir J, 53 (5) 1702020; 10.1183/13993003.02020-2017
Journal Issue: May
Disease area: Paediatric lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Francesca Pennati, Caterina Salito, Irene Borzani, Giulia Cervellin, Simone Gambazza, Riccardo Guarise, Maria Chiara Russo, Carla Colombo, Andrea Aliverti. Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators. Eur Respir J, 53 (5) 1702020; 10.1183/13993003.02020-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Multivolume magnetic resonance imaging (1H-MRI) for the longitudinal assessment of cystic fibrosis (CF) lung disease: comparison with spirometry
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




Assessment of chest magnetic resonance imaging in non-cystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with clinical and pulmonary function data
Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease
Year: 2009


Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease
Source: Eur Respir J, 50 (6) 1701464; 10.1183/13993003.01464-2017
Year: 2017



Assessment of a new magnetic resonance imaging (MRI)-scoring- system for pulmonary changes in patients with cystic fibrosis (CF) – comparison with clinical parameters and high resolution computed tomography (HRCT)
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006


Functional magnetic resonance imaging and lung function tests in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017

Magnetic resonance imaging (MRI) as a non-invasive, radiation-free imaging modality to study the onset and progression of lung disease in infants and young children with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: detection and monitoring of early lung disease
Year: 2011

Role of chest magnetic resonance imaging (MRI) in the assessment and follow up of patients with cystic fibrosis (CF)
Source: Annual Congress 2010 - Infection, inflammation and destruction
Year: 2010

Quantitative multivolume magnetic resonance imaging (1H-MRI) in patients with cystic fibrosis (CF) lung disease:comparison with FEV1 and lung clearance index (LCI)
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017

Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging
Source: Eur Respir J, 50 (1) 1601437; 10.1183/13993003.01437-2016
Year: 2017



Comparison of 1H MRI and 3He MRI ventilation images in patients with cystic fibrosis and patients with lung cancer
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018



Hyperpolarised 129Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis
Source: Eur Respir J, 53 (5) 1802188; 10.1183/13993003.02188-2018
Year: 2019



Evaluation of the peripheral airway microstructure in children with cystic fibrosis (CF) using 3He magnetic resonance imaging
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new therapies and detection of early lung disease
Year: 2012

Gadofosveset-enhanced lung magnetic resonance imaging to detect ongoing vascular leak in pulmonary fibrosis
Source: Eur Respir J, 51 (5) 1800171; 10.1183/13993003.00171-2018
Year: 2018



Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial
Source: Eur Respir J 2009; 34: 1311-1321
Year: 2009



Magnetic resonance imaging (MRI) of the lung as a tool for the non-invasive evaluation of drugs in rat models of airways diseases
Source: Annual Congress 2005 - New modalities and application in lung and airway imaging
Year: 2005


Comparison of in-vivo lung morphometry models from multiple b-value diffusion-weighted MRI in healthy controls, IPF and COPD patients
Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Year: 2017



Non-contrast-enhanced assessment of lung perfusion in CF patients during respiratory tract exacerbation using Fourier decomposition magnetic resonance imaging (FDMRI)
Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI
Year: 2020

Imaging of cystic fibrosis: functional MRI versus conventional CT
Source: Annual Congress 2007 - Imaging of inflammatory airway diseases
Year: 2007


The use of chest magnetic resonance imaging in interstitial lung disease: a systematic review
Source: Eur Respir Rev, 27 (150) 180062; 10.1183/16000617.0062-2018
Year: 2018